NVIDIA Corporation

Salesforce, Inc.

Nvidia securities are also trading in the negative zone despite the strong report

Nvidia's report failed to support the markets, with the S&amp;P 500 and Nasdaq losing more than 1%

Chinese stocks may rise by 20% as rising inflation expectations lead to better corporate earnings, according to analysts at UBS Securities Asia. Their opinion is <a href="https://www.bloomberg.com/news/articles/2026-02-26/ubs-sees-20-upside-for-china-stocks-on-reflationary-potential">published by</a> Bloomberg.

UBS expects Chinese stocks to rise 20%. What can push the market?

Taiwan Semiconductor Manufacturing Company Limited

Cisco Systems, Inc.

Cult short-seller Michael Burry, who reported a bet against Nvidia last year, believes the chipmaker will repeat the fate of dot-com bubble-era Cisco due to an abnormal rise in purchase commitments

"$117 billion trap": what risk did a Downgrade Game investor find in Nvidia's report

Rolls-Royce Holdings plc

Booming demand for aviation and data center engines has allowed the manufacturer to sharply raise its earnings forecasts through 2028

Rolls-Royce shares hit a record after the report. They are growing faster than Nvidia securities

PUMA SE

German sports retailer Puma has canceled dividend payments and <a href="https://about.puma.com/en/newsroom/corporate-news/2026/26-02-2026-puma-completes-reset-2025-2026-designated-transition-year">said</a> it expects another loss this year. At the same time, the company's losses for last year were less than analysts predicted. This supported the quotes of Puma on Thursday, February 26.

Puma warned of losses and lower revenue in the coming year. Why the stock is rising

The Citrini Report is a super-optimistic report. A close look at <a href="https://oninvest.com/article/obval-akcij-na-38-i-vvp-prizrak-o-cem-govoritsa-v-virusnom-otcete-o-budusem-s-ii">this text</a> shows that its authors believe in the omnipotence of artificial intelligence much more than all the AI analysts in the Trump administration: if the Trump administration were so confident in the omnipotence of AI, they would only think about regulating it, according to AI researcher <a href="https://www.facebook.com/mikaelalemu251">Mikael Gorsky</a>.

Should we be worried about the fate of the world: three reasons to ignore the Citrini report

Stellantis N.V.

The auto industry's financial losses due to the winding down of investments in electric vehicle projects have exceeded $50 billion in recent months, The Wall Street Journal has estimated

The maker of Jeep and Fiat ended the year with a loss for the first time in history due to electric cars

Bajaj Consumer Care Limited

MTAR Technologies Limited

MRV Engenharia e Participacoes S.A.

Last year showed that small caps in emerging markets can compete with large issuers, despite a <a href="https://en.oninvest.com/article/undervalued-small-caps-where-to-make-money-in-emerging-markets">lag</a>&nbsp;that persisted through the third quarter. For 2025, the return of the Equal Weight EM Small Cap Index, put together by analyst Aldiyar Anuarbekov for Oninvest, amounted to 18.25% in dollar terms*. For comparison: the broad-market S&amp;P 500 index grew 16.65%, while the smid-cap Russell 2000 rose 11.21% last year. The 8.06% increase in the Cap Weight EM Small Cap Index, meanwhile, indicates that the gains were more evenly distributed rather than concentrated in a small number of large stocks.

Where to find outstripping returns in EM small caps in 2026

Dutch Bros Inc.

Dutch Bros, a small U.S. coffee chain, is a growth stock that "could supercharge your returns over the next five years and beyond," <a href="https://www.fool.com/investing/2026/02/26/growth-stock-supercharge-invest-return-5-years/">argues</a>&nbsp;Motley Fool contributing analyst Neil Patel. The company’s stock is trading about 45% below its peak even as its fundamentals remain strong, he says, creating an attractive entry point for investors.

Motley Fool analyst likes growing U.S. coffee chain Dutch Bros on dip

VolitionRx Limited

Shares of VolitionRx, a micro-cap developer of blood tests for cancer and sepsis, <a href="https://finance.yahoo.com/quote/VNRX/">jumped</a>&nbsp;nearly 26% on Tuesday after the company <a href="https://ir.volition.com/news-events/press-releases/detail/874/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution">reported</a>&nbsp;progress in several research programs and said a newly developed cancer-detection method has attracted interest from potential partners. The company also highlighted breakthrough research on detecting lymphoma in cats. Wall Street analysts <a href="https://www.marketwatch.com/investing/stock/vnrx/analystestimates?mod=mw_quote_tab">say</a>&nbsp;the stock could have nearly 790% upside.

Cancer blood test maker VolitionRX soars 25% in a day on reported commercial progress

IonQ, Inc.

Nutanix, Inc.

Synopsys, Inc.

Advanced Micro Devices, Inc.

The Trade Desk, Inc.

Warner Bros. Discovery, Inc.

Paramount Skydance Corporation

Netflix, Inc.

Thomson Reuters Corporation

United Therapeutics Corporation

Circle Internet Group

Clear Secure, Inc.

Jazz Pharmaceuticals plc

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

New York morning: markets assess Nvidia report and look for new drivers

What are analysts saying about the results of one of the AI race leaders and what to expect from it next?

Oil